Literature DB >> 3620718

Long-term adjuvant tamoxifen study: clinical update.

D C Tormey, P Rasmussen, V C Jordan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3620718     DOI： 10.1007/bf01807370

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  7 in total

Review 1.  Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

2.  Effects of anti-estrogens on bone in castrated and intact female rats.

Authors:  V C Jordan; E Phelps; J U Lindgren
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

3.  The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

Review 4.  Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.

Authors:  V Craig Jordan; Angela M H Brodie
Journal:  Steroids       Date:  2006-12-13       Impact factor: 2.668

Review 5.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

Review 6.  50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2021-01       Impact factor: 5.678

Review 7.  Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles.

Authors:  Candace M Day; Shane M Hickey; Yunmei Song; Sally E Plush; Sanjay Garg
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.